Show simple item record

dc.contributor.authorPinto, A
dc.contributor.authorDaly, A
dc.contributor.authorRocha, JC
dc.contributor.authorAshmore, C
dc.contributor.authorEvans, S
dc.contributor.authorIlgaz, F
dc.contributor.authorHickson, M
dc.contributor.authorMacDonald, A
dc.date.accessioned2024-01-02T11:09:01Z
dc.date.available2024-01-02T11:09:01Z
dc.date.issued2023-11-23
dc.identifier.issn2072-6643
dc.identifier.issn2072-6643
dc.identifier.other4903
dc.identifier.urihttps://pearl.plymouth.ac.uk/handle/10026.1/21860
dc.description.abstract

In phenylketonuria (PKU), an important component of the UK dietary management system is a 50 mg phenylalanine (Phe)/1 g protein exchange system used to allocate the Phe/natural protein intakes according to individual patient tolerance. Any foods containing protein ≤ 0.5 g/100 g or fruits/vegetables containing Phe ≤ 75 mg/100 g are allowed without measurement or limit. In children with PKU, we aimed to assess the difference between the prescribed natural protein intake and their actual consumed intake, and to calculate the natural protein/Phe intake from foods given without measurement or restriction. Over a 6-month duration, three one-day diet diaries were collected every month by caregivers of children with PKU at the beginning of a follow-up study. Dietary intakes of Phe, as well as natural and total protein intakes, were calculated using Nutritics® (v5.09). Weekly blood Phe spots were collected by caregivers. The target blood Phe level was ≤360 μmol/L for ages up to 12 years and ≤600 μmol/L for ages ≥12 years. Sixteen early treated children (69% females) with PKU were recruited. The median age was 11 years (range: 9–13), and most had classical PKU (n = 14/16). A median of 18 (range 12–18) one-day diaries and 22 blood spots were analysed for each subject over 6 months. The median prescribed natural protein was 6 g/day (range: 3–27), but when calculated, the actual median intake from all foods consumed was 10 g/day (range: 4–37). The median prescribed Phe was 300 mg/day (range: 150–1350), but the actual median intake was 500 mg/day (range: 200–1850). The median difference between the prescribed and actual natural protein daily intakes was +4 g/day (range: −2.5 to +11.5), with a median percentage increase of 40% for natural protein/Phe intake (p < 0.001). The median blood Phe level was 250 μmol/L (range 20–750), with 91% of blood Phe levels within the target range. Only one patient (11 years) had less than 75% of their blood Phe levels within the target range. The UK Phe exchange system provides flexibility in the dietary management of PKU. With this method, the actual natural protein intake was 167% higher than the prescribed amount. Although this led to a variable daily protein intake, the majority of children (n = 15/16) experienced no deterioration in their metabolic control.

dc.format.extent4903-4903
dc.format.mediumElectronic
dc.languageen
dc.publisherMDPI AG
dc.subjectphenylketonuria
dc.subjectfruits
dc.subjectvegetables
dc.subjectmetabolic control
dc.subjectphenylalanine
dc.titleNatural Protein Intake in Children with Phenylketonuria: Prescription vs. Actual Intakes
dc.typejournal-article
dc.typeArticle
plymouth.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/38068761
plymouth.issue23
plymouth.volume15
plymouth.publisher-urlhttp://dx.doi.org/10.3390/nu15234903
plymouth.publication-statusPublished online
plymouth.journalNutrients
dc.identifier.doi10.3390/nu15234903
plymouth.organisational-group|Plymouth
plymouth.organisational-group|Plymouth|Research Groups
plymouth.organisational-group|Plymouth|Faculty of Health
plymouth.organisational-group|Plymouth|Faculty of Health|School of Health Professions
plymouth.organisational-group|Plymouth|Research Groups|Institute of Health and Community
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA
plymouth.organisational-group|Plymouth|Users by role
plymouth.organisational-group|Plymouth|Users by role|Academics
plymouth.organisational-group|Plymouth|REF 2021 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
plymouth.organisational-group|Plymouth|Research Groups|Plymouth Institute of Health and Care Research (PIHR)
plymouth.organisational-group|Plymouth|REF 2028 Researchers by UoA
plymouth.organisational-group|Plymouth|REF 2028 Researchers by UoA|UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy
dc.publisher.placeSwitzerland
dcterms.dateAccepted2023-11-19
dc.date.updated2024-01-02T11:08:55Z
dc.rights.embargodate2024-1-27
dc.identifier.eissn2072-6643
rioxxterms.versionofrecord10.3390/nu15234903


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV